The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Urokinase-type plasminogen activator receptor in IgA nephropathy

  • Ahn, Shin-Young (Department of Internal Medicine, Seoul National University Bundang Hospital) ;
  • Chin, Ho Jun (Department of Internal Medicine, Seoul National University Bundang Hospital)
  • Received : 2014.02.09
  • Accepted : 2014.02.10
  • Published : 2014.03.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Lee H, Kim DK, Oh KH, et al. Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases. Am J Nephrol 2013;37:74-83. https://doi.org/10.1159/000345960
  2. Lee H, Kim DK, Oh KH, et al. Mortality of IgA nephropathy patients: a single center experience over 30 years. PLoS One 2012;7:e51225. https://doi.org/10.1371/journal.pone.0051225
  3. Lemley KV, Lafayette RA, Safai M, et al. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002;61:1475-1485. https://doi.org/10.1046/j.1523-1755.2002.00269.x
  4. Hill GS, Karoui KE, Karras A, et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies. Kidney Int 2011;79:635-642. https://doi.org/10.1038/ki.2010.466
  5. El Karoui K, Hill GS, Karras A, et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int 2011;79:643-654. https://doi.org/10.1038/ki.2010.460
  6. Menon MC, Chuang PY, He JC. Role of podocyte injury in IgA nephropathy. Contrib Nephrol 2013;181:41-51. https://doi.org/10.1159/000348461
  7. Lai KN, Tang SC, Guh JY, et al. Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol 2003;14:3127-3137. https://doi.org/10.1097/01.ASN.0000095639.56212.BF
  8. Lopez-Armada MJ, Gomez-Guerrero C, Egido J. Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. J Immunol 1996;157:2136-2142.
  9. Lai KN, Leung JC, Chan LY, et al. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 2009;24:62-72.
  10. Wang C, Liu X, Ye Z, et al. Mesangial medium with IgA1 from IgA nephropathy inhibits nephrin expression in mouse podocytes. Eur J Clin Invest 2009;39:561-567. https://doi.org/10.1111/j.1365-2362.2009.02135.x
  11. Luft FC. uPAR signaling is under par for the podocyte course. J Mol Med (Berl) 2012;90:1357-1359. https://doi.org/10.1007/s00109-012-0980-2
  12. Zhang G, Eddy AA. Urokinase and its receptors in chronic kidney disease. Front Biosci 2008;13:5462-5478.
  13. Wei C, Moller CC, Altintas MM, et al. Modification of kidney barrier function by the urokinase receptor. Nat Med 2008;14:55-63. https://doi.org/10.1038/nm1696
  14. Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011;17:952-960. https://doi.org/10.1038/nm.2411
  15. Gueler F, Rong S, Mengel M, et al. Renal urokinase-type plasminogen activator (uPA) receptor but not uPA deficiency strongly attenuates ischemia reperfusion injury and acute kidney allograft rejection. J Immunol 2008;181:1179-1189. https://doi.org/10.4049/jimmunol.181.2.1179
  16. Xu Y, Berrou J, Chen X, et al. Induction of urokinase receptor expression in nephrotoxic nephritis. Exp Nephrol 2001;9:397-404. https://doi.org/10.1159/000052638
  17. Zhang G, Kim H, Cai X, et al. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 2003;14:1254-1271. https://doi.org/10.1097/01.ASN.0000064292.37793.FB
  18. Zhang B, Shi W, Ma J, et al. The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. J Mol Med (Berl) 2012;90:1407-1420. https://doi.org/10.1007/s00109-012-0960-6
  19. Zhang B, Xie S, Shi W, Yang Y. Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria. Nephrol Dial Transplant 2012;27:1746-1755. https://doi.org/10.1093/ndt/gfr612
  20. Chen X, Qiu Q, Tang L, et al. Effects of co-administration of urokinase and benazepril on severe IgA nephropathy. Nephrol Dial Transplant 2004;19:852-857. https://doi.org/10.1093/ndt/gfh069
  21. Yamaguchi I, Lopez-Guisa JM, Cai X, Collins SJ, Okamura DM, Eddy AA. Endogenous urokinase lacks antifibrotic activity during progressive renal injury. Am J Physiol Renal Physiol 2007;293:F12-F19. https://doi.org/10.1152/ajprenal.00380.2006
  22. Lee JH, Oh MH, Park JS, et al. Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis. Korean J Intern Med 2014;29:176-182. https://doi.org/10.3904/kjim.2014.29.2.176